Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 4
1959 2
1961 3
1962 2
1964 4
1966 1
1968 1
1970 1
1976 1
1981 1
1983 1
1984 1
1990 2
1991 2
1992 2
1993 1
1994 3
1995 1
1996 1
1997 1
1998 3
1999 1
2000 2
2001 1
2002 2
2003 2
2004 1
2005 2
2006 3
2007 2
2008 3
2009 3
2010 5
2011 5
2012 4
2013 4
2014 4
2015 8
2016 7
2017 6
2018 7
2019 4
2020 7
2021 14
2022 9
2023 11
2024 10
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.
Guo C, Sharp A, Gurel B, Crespo M, Figueiredo I, Jain S, Vogl U, Rekowski J, Rouhifard M, Gallagher L, Yuan W, Carreira S, Chandran K, Paschalis A, Colombo I, Stathis A, Bertan C, Seed G, Goodall J, Raynaud F, Ruddle R, Swales KE, Malia J, Bogdan D, Tiu C, Caldwell R, Aversa C, Ferreira A, Neeb A, Tunariu N, Westaby D, Carmichael J, Fenor de la Maza MD, Yap C, Matthews R, Badham H, Prout T, Turner A, Parmar M, Tovey H, Riisnaes R, Flohr P, Gil J, Waugh D, Decordova S, Schlag A, Calì B, Alimonti A, de Bono JS. Guo C, et al. Among authors: colombo i. Nature. 2023 Nov;623(7989):1053-1061. doi: 10.1038/s41586-023-06696-z. Epub 2023 Oct 16. Nature. 2023. PMID: 37844613 Free PMC article.
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial.
Colombo N, Biagioli E, Harano K, Galli F, Hudson E, Antill Y, Choi CH, Rabaglio M, Marmé F, Marth C, Parma G, Fariñas-Madrid L, Nishio S, Allan K, Lee YC, Piovano E, Pardo B, Nakagawa S, McQueen J, Zamagni C, Manso L, Takehara K, Tasca G, Ferrero A, Tognon G, Lissoni AA, Petrella M, Laudani ME, Rulli E, Uggeri S, Barretina Ginesta MP; AtTEnd study group. Colombo N, et al. Lancet Oncol. 2024 Sep;25(9):1135-1146. doi: 10.1016/S1470-2045(24)00334-6. Epub 2024 Aug 2. Lancet Oncol. 2024. PMID: 39102832 Clinical Trial.
Kidney-gut crosstalk in renal disease.
Colombo I, Aiello-Battan F, Elena R, Ruiz A, Petraglia L, Musso CG. Colombo I, et al. Ir J Med Sci. 2021 Aug;190(3):1205-1212. doi: 10.1007/s11845-020-02437-7. Epub 2020 Nov 20. Ir J Med Sci. 2021. PMID: 33216316 Review.
Moving From Mutation to Actionability.
Colombo I, Kurnit KC, Westin SN, Oza AM. Colombo I, et al. Am Soc Clin Oncol Educ Book. 2018 May 23;38:495-503. doi: 10.1200/EDBK_199665. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231353 Free article. Review.
Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial.
Mc Laughlin AM, Hess D, Michelet R, Colombo I, Haefliger S, Bastian S, Rabaglio M, Schwitter M, Fischer S, Eckhardt K, Hayoz S, Kopp C, Klose M, Sessa C, Stathis A, Halbherr S, Huisinga W, Joerger M, Kloft C. Mc Laughlin AM, et al. Among authors: colombo i. Cancer Chemother Pharmacol. 2024 Sep;94(3):349-360. doi: 10.1007/s00280-024-04679-z. Epub 2024 Jun 15. Cancer Chemother Pharmacol. 2024. PMID: 38878207 Free PMC article. Clinical Trial.
Radiomics in cervical and endometrial cancer.
Manganaro L, Nicolino GM, Dolciami M, Martorana F, Stathis A, Colombo I, Rizzo S. Manganaro L, et al. Among authors: colombo i. Br J Radiol. 2021 Sep 1;94(1125):20201314. doi: 10.1259/bjr.20201314. Epub 2021 Jul 8. Br J Radiol. 2021. PMID: 34233456 Free PMC article. Review.
Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer.
Lheureux S, Matei DE, Konstantinopoulos PA, Wang BX, Gadalla R, Block MS, Jewell A, Gaillard SL, McHale M, McCourt C, Temkin S, Girda E, Backes FJ, Werner TL, Duska L, Kehoe S, Colombo I, Wang L, Li X, Wildman R, Soleimani S, Lien S, Wright J, Pugh T, Ohashi PS, Brooks DG, Fleming GF. Lheureux S, et al. Among authors: colombo i. J Immunother Cancer. 2022 Mar;10(3):e004233. doi: 10.1136/jitc-2021-004233. J Immunother Cancer. 2022. PMID: 35288469 Free PMC article. Clinical Trial.
Drug mechanochemical activation.
Colombo I, Grassi G, Grassi M. Colombo I, et al. J Pharm Sci. 2009 Nov;98(11):3961-86. doi: 10.1002/jps.21733. J Pharm Sci. 2009. PMID: 19338060 Review.
160 results